Drawing for LYCOMPLI

USPTO serial 79252369

LYCOMPLI

Reviewed by CopyMark Law Group

Reg. 5876765Status 404
Filing date
Status date
Registration date
Oct 8, 2019
Examiner
CHOSID, ROBIN S
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LYCOMPLI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005[ Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; ] pharmaceutical preparations for use in hematology and in tissue and organ transplantation; [ pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; ] pharmaceutical preparations for the prevention and treatment of cancer and tumors [ ; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]SECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 10, 2022DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Dec 10, 2022DETHDEATH OF INTERNATIONAL REGISTRATION
Sep 10, 2020INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Aug 5, 2020INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 27, 2019GPNXNOTIFICATION PROCESSED BY IB
Dec 12, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB
Dec 12, 2019FIMPFINAL DISPOSITION PROCESSED
Dec 10, 2019LIMELIMITATION FROM THE IB EXAMINED AND ENTERED
Dec 10, 2019LIMELIMITATION FROM THE IB EXAMINED AND ENTERED
Dec 5, 2019COC.CORRECTION UNDER SECTION 7 - PROCESSED
Dec 5, 2019PLGLASSIGNED TO PARALEGAL
Nov 8, 2019ES7RTEAS SECTION 7 REQUEST RECEIVED
Nov 7, 2019GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB
Oct 8, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 27, 2019LIMGLIMITATION OF GOODS RECEIVED FROM IB
Sep 1, 2019ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 8, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 5, 2019LIMGLIMITATION OF GOODS RECEIVED FROM IB
May 21, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Apr 23, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 3, 2019NPUBNOTICE OF PUBLICATION
Mar 12, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2019DOCKASSIGNED TO EXAMINER
Mar 2, 2019MAFRAPPLICATION FILING RECEIPT MAILED
Feb 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 21, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance